About BioStar Pharmaceuticals, Inc.

BioStar Pharmaceuticals, Inc. engages in the development, manufacture, and marketing of pharmaceutical and health supplement products for a variety of diseases and conditions. It's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter medicine for chronic hepatitis B, a disease affecting the Chinese population. The company was founded on March 27, 2007 and is headquartered in Xianyang, China.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a profit of 0.68$ per share.

The book value per share is 13.71$

BioStar Pharmaceuticals, Inc. website


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- -11.60% 3M 792.90% 1M 0.68 - - 3M 13.71 9M - 9M